Table 1.
Number of male: female respondents | % male | Median (IQR) age | Median (IQR) duration of symptoms in months | |
---|---|---|---|---|
Greater trochanteric pain syndrome (n = 75) | 14:61 | 19% | 62.0 (48.8–69.4) | 30.0 (18.0–48.0) |
Quadriceps tendinopathy (n = 4) | 3:1 | 75% | 36.2 (33.0–41.9) | 36.0 (31.5–42.0) |
Patellar tendinopathy (n = 10) | 9:1 | 90% | 41.8 (37.3–43.1) | 15.5 (11.3–22.5) |
Mid-substance Achilles tendinopathy (n = 31) | 13:18 | 42% | 48.3 (41.9–52.6) | 21.0 (15.3–28.5) |
Insertional Achilles tendinopathy (n = 36) | 16:20 | 44% | 57.1 (48.2–62.4) | 18.0 (12.0–30.0) |
Plantar fasciitis (n = 126) | 43:83 | 34% | 50.2 (42.7–58.0) | 24.0 (15.8–36.0) |
All patients (n = 282) | 98:184 | 35% | 51.9 (44.0–61.8) | 24.0 (12.0–36.0) |
IQR: interquartile range.